Bausch Health Companies Inc [BHC] stock prices are up 2797755% to $2490000.0 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The BHC shares have gain 12.16% over the last week, with a monthly amount glided 32.05%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Bausch Health Companies Inc [NYSE: BHC] stock has seen the most recent analyst activity on August 02, 2024, when Piper Sandler downgraded its rating to a Underweight and also revised its price target to $3 from $9. Previously, Raymond James started tracking the stock with Mkt Perform rating on July 10, 2024, and set its price target to $8. On September 20, 2023, upgrade upgraded it’s rating to Buy and revised its price target to $16 on the stock. TD Cowen downgraded its rating to a Market Perform. Truist downgraded its rating to a Hold. RBC Capital Mkts downgraded its rating to Sector Perform for this stock on July 29, 2022, and downed its price target to $5. In a note dated July 28, 2022, JP Morgan downgraded an Neutral rating on this stock.
The stock price of Bausch Health Companies Inc [BHC] has been fluctuating between $3.96 and $9.85 over the past year. Currently, Wall Street analysts expect the stock to reach $10 within the next 12 months. Bausch Health Companies Inc [NYSE: BHC] shares were valued at $2490000.0 at the most recent close of the market. An investor can expect a potential drop of -100.0% based on the average BHC price forecast.
Analyzing the BHC fundamentals
The Bausch Health Companies Inc [NYSE:BHC] reported sales of 9.73B for trailing twelve months, representing a surge of 4.92%. Gross Profit Margin for this corporation currently stands at 0.65% with Operating Profit Margin at 0.16%, Pretax Profit Margin comes in at 0.02%, and Net Profit Margin reading is -0.0%. To continue investigating profitability, this company’s Return on Assets is posted at -0.0, Equity is 0.05 and Total Capital is 0.06.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It’s worth pointing out that Bausch Health Companies Inc [NYSE:BHC]’s Current Ratio is 1.35. Further, the Quick Ratio stands at 0.97. Considering the valuation of this stock, the price to sales ratio is 0.23.
Transactions by insiders
Recent insider trading involved Paulson John, Director, that happened on Jun 13 ’25 when 3.56 million shares were purchased. Director, Paulson John completed a deal on Jun 12 ’25 to buy 1.01 million shares. Meanwhile, Director Paulson John bought 1.03 million shares on Jun 11 ’25.
